OUR 2026 USANZ BLADDER CANCER HIGHLIGHTS

USANZ 2026, in its 30th year, offers fresh and exciting opportunities for continuing professional development offered by national and international experts. Highlights of the program that pertain to Bladder Cancer, or selected related issues, or are presented or chaired by our co-founder and co-chair, Professor Nathan Lawrentschuk and former board member Shane Qin, include:Saturday, 28th […]

Read More

New bladder cancer treatments and how they work

Non-muscle-invasive bladder cancer (NMIBC) is a form of bladder cancer that remains within the bladder lining and has not invaded deeper tissues. Standard treatments, such as intravesical (“in-bladder”) Bacillus Calmette-Guérin (BCG) (a live attenuated bacteria) or chemotherapy, are usually effective. However, these treatments may fail to control the disease for some patients.

Read More